Neumoloxía
Servizo
![Foto de Neumoloxía](/img/noimage.png)
![Foto de GlaxoSmithKline (United Kingdom)](/img/noimage_org.png)
GlaxoSmithKline (United Kingdom)
Londres, Reino UnidoPublicacións en colaboración con investigadores/as de GlaxoSmithKline (United Kingdom) (5)
2024
-
Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial
Archivos de Bronconeumologia
2021
-
Cost-effectiveness analysis of anti–IL-5 therapies of severe eosinophilic asthma in Spain
Journal of Medical Economics, Vol. 24, Núm. 1, pp. 874-882
2020
-
Characteristics and treatment regimens across ERS SHARP severe asthma registries
European Respiratory Journal, Vol. 55, Núm. 1
2017
-
Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease
Journal of the American Medical Directors Association, Vol. 18, Núm. 12, pp. 1097.e11-1097.e24
2005
-
Inhibition of iNOS activity by 1400W decreases glutamate release and ameliorates stroke outcome after experimental ischemia
Neurobiology of Disease, Vol. 18, Núm. 2, pp. 375-384